T. Rowe Price Associates’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-17,840
| Closed | -$603K | – | 3029 |
|
|
2021
Q2 | $603K | Sell |
17,840
-524,199
| -97% | -$17.7M | ﹤0.01% | 2293 |
|
|
2021
Q1 | $12.7M | Buy |
542,039
+284,777
| +111% | +$6.66M | ﹤0.01% | 1353 |
|
|
2020
Q4 | $7.41M | Sell |
257,262
-216,071
| -46% | -$6.22M | ﹤0.01% | 1387 |
|
|
2020
Q3 | $9.59M | Buy |
473,333
+199,294
| +73% | +$4.04M | ﹤0.01% | 1309 |
|
|
2020
Q2 | $8.24M | Sell |
274,039
-253,828
| -48% | -$7.63M | ﹤0.01% | 1324 |
|
|
2020
Q1 | $16.6M | Buy |
527,867
+124,292
| +31% | +$3.91M | ﹤0.01% | 1122 |
|
|
2019
Q4 | $19M | Buy |
403,575
+53,350
| +15% | +$2.51M | ﹤0.01% | 1199 |
|
|
2019
Q3 | $2K | Buy |
350,225
+32
| +0% | – | ﹤0.01% | 2508 |
|
|
2019
Q2 | $4K | Buy |
+350,193
| New | +$4K | ﹤0.01% | 2533 |
|